comprehensive -WSS

comprehensive

author：leisure time 2025-09-03 03:37:26 - browse：325

Sutter Health Palo Alto Medical Foundation facilities. health tech coverage from STAT — Adobe

When Sutter Health was on trial for anticompetitive conduct in 2022, the San Francisco jury missed out on some crucial details. They didn’t hear, for example, how its former finance chief said the system would make an extra $200 million per year by making insurers contract with all of its hospitals instead of just a few. Or how its former CEO said, “Related to the health plans, we force them to pay us more.”

That evidence was indeed relevant, and the judge erred by not allowing it to be presented during the month-long trial that concluded in March 2022, a U.S. appeals court wrote in its ruling on Tuesday. The Ninth Circuit panel overturned Sutter’s win in the class-action case alleging that Sutter used its market power to drive up health care costs across the region by more than $400 million. Tuesday’s decision means the case will likely get a second trial.

“Effectively, the appellate court said the jury was tainted,” said Matthew Cantor, lead counsel for the plaintiffs. “So the jury’s verdict is discarded.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Radiology is caught between AI's potential and concern for patients

explore

WSS

Stigma and the return of syphilis

Stigma and the return of syphilis

Patients' immediate access to test results puts radiologists in a bind

First Opinion Podcast: What happens when kids become caregivers?

Average age of first period drops to 11.9 years, study shows

Why sickle cell disease is getting the first CRISPR treatment

hotspot

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the financial innards of our health care system — by subscribing to STAT+.

hotspot

Anesthesiologist group: stop taking Ozempic before surgery

Startling documents reveal new facets of Sacklers' opioid empire

Hollywood unions extend contract negotiations for actors

First Opinion Podcast: What happens when kids become caregivers?

Supreme Court strikes down use of affirmative action

Congenital heart disease patients face new threat of heart failure

Bright Health sells Medicare Advantage business to Molina

Report: NIH

How to save PrEP access — and even expand it

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

hotspot

Prosthetic arm enables patients to feel the objects they grip

FDA approves world's first CRISPR

Merus drug and Keytruda shrank tumors in patients with head and neck cancer

FDA approves world's first CRISPR

Teach medical students about patients with intellectual disabilities

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

hotspot

entertainment

explore

Wikipedia